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lgF NMR in the measurement of binding affinities of 
chloroeremomycin to model bacterial cell-wall surfaces 
that mimic VanA and VanB resistance 
Richard MH Entress, Robert J Dancer, Dominic P O’Brien, Andrew C Try, 
Matthew A Cooper and Dudley H Williams 
Background: The emergence of bacteria that are resistant to vancomycin, the 
drug of choice against methicillin-resistant Staphylococcus aureus, has made the 
study of the binding characteristics of glycopeptides to biologically relevant 
depsipeptides important. These depsipeptides, terminating in -D-ahyl-D-kdate, 
mimic the cell-wall precursors of resistant bacteria. 
Results: The use of lgF-labelled ligands in the study of the therapeutically 
important vancomycin series of antibiotics is demonstrated. The substantial 
simplification of spectra that occurs when such labelled ligands are employed 
is used in the measurement of binding affinities of depsipeptides to 
chloroeremomycin (CE). Large enhancements of binding affinities are found at 
a model bacterial cell-wall surface (constituted from depsipetides that are 
anchored into vesicles) relative to those measured in free solution. 
Conclusions: Surface-enhanced binding, previously shown for strongly 
dimerising glycopeptide antibiotics to normal -D-alanyl-D-alanine-terminating 
cell-wall precursors, is now demonstrated for CE to the surface of models of 
VanA- and VanB-resistant bacteria. The effect of depsipeptide chain length is 
shown to be critically important in producing and maximising this enhancement. 
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Introduction 
‘he clinically irnport2mt \-ancotnycin group of antibiotics 
bind ro the cell-WLIII precursor (~,j-~.-\(~-N:\\l-al~~i~~i- 
II-glutam) I-l\-s\-l-I)-alan~l-I)-~ll~lnine on the surtkc of 
gram-positi1.e bacterial tncnihrancs. inhibiting cell-uall 
hios\-nthesis, Icuding to the death of the hacrerium [ 1.21. 
‘l‘hw art: now the last line of defencc ;tgainst man) strains 
of k;athogenic bacteria. especially methicillin-resistanr 
<\‘k//I.‘l,l’/,, (JCCfl.i NII/?I(.C ( h 1 RSX) [ :1 ,A]. 
‘I‘hcsc antibiotics, II ith the exception of tcicoplanin, ha\ e 
ken shown to diincrise dong the opposite fxc of the 
;mtit,iotic ro that in\vl\zd in ligand binding [.5-T]. For most 
of rhose antibiotics that dimerise, it has been sho\+.n thx 
the binding of 2 ligand I0 these antibiotics incrcsxes their 
dimcrisation conswnts and that dimcrisation leads to higher 
binding consrants, that is. dimerisation is cooperatiw 11 irh 
ligand binding did ~C,+OJ w/w [S]. 
I’re\ ious work in this grorlp [X,9] has demonstrated that 
rhcre is an increase in the fret energy of binding of glyco- 
pqxide antibio&x to cctl-\2all precursors \vhcn the) arc 
hound to ;I model cell-\vall system rather than cell-wall 
precursors in free solution. FTC define the complex formed 
Ixtwccn an 3ntihiotic dimer bound to wo surfrice-bound 
ligands ~1s ;I tcmplated complex. \\:hen a dimeric antibiotic 
hinds to the cell surfwe. ;I significanr portion of rhc 
entropic cost of hindin g IS paid in the first binding cwnt 
and hence the xcond binding ucnt l~ecomes cffccti\,el\ 
intr;lmolec~ilar. ‘l’his chelatc-lib enh;incemcnt resulrs in 
srrongcr binding to lipnd and hence an increase in bio- 
logical activit)- [5,9.10]. \Ye ha\ c prwiously demonstr3rcci 
an eacellcnt corrcl:ition bot\\cen binding constants nica- 
sured in such model systems with the corresponding 
binding conwnts on chc ~lctud hacteri;ll surfxe IX.1 11. 
It is hnown th:it bacteria become rcsisunt to vancomycin 
through die modification of the terminal I)-alanine (I)-;\lkr) 
residue in their growing cell \\all to Iblactare (I)-I,ac). 
'I‘he ti-;iilsformalioii of :rn aniidc t)ond I0 :rn eswr replace\ 
xii :itrracriw cartx)nyl-NI I hydrogen bond \I ith ;I rcpu- 
si\ c interacrion bet\\ een the ester oxygen from rhe II-1 .:ic 
2nd the same c:irbonyl group \I irhin the binding pocket ot 
the :inribiotic (I-igiire 1) (12.13]. ‘l‘his substanriall) 
rcdt~ces the binding affinit-) of the Lint-ibiotic in solution 
(K,, mo\ cs from 1.3 x 10” \I-’ for chlorocrcmoln\-tin (CE) 
bound to di-~\-acct~l-l~s~l-l~-~il~in~l-i~-~il~ii~in~ (Xc’I’ri- 
;ila) to 920 \I-’ hound to cli-~~-acet~l-l~s\-1-1~-~il~in~l-l~- I 
IacLltc (:\c-‘r‘ri-Lx)). It is this reducCon in binding th;it 
~ippears to render the antibiotic, :md the closely related 
antibiotic \2nconiwin. thcrapcuticall\ llseless againsr 
\vkin.+ and I7anH-rcsistanr tuctcria [l+161. I Ience. the 
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Figure 1 
(a) 
Ac-Di-Ala 
Antibiotic-binding pocket 
, Chemistry & Rology 
Antibiotlc-binding pocket 1 
Resistance to vancomycin. In vancomycln-reslstant enterococci, the 
terminal o-alanine residue of the immature cell wall has been replaced 
by D-b&3te. This change drastically reduces the blnding affintty to 
glycopeptldes, as an NH group (a), which can form a hydrogen bond, 
is replaced by an oxygen atom (b). 
binding affinities of lactate-terminating ligands at 3 
surfxc are of great interest. \Yc no\v demonstrate a uscfi~l 
and novel method for the determination of binding con- 
stants of \,ancoin)-tin-grollp antibiotics to model bacterial 
surfaces in general. and in particular to those bearing 
I>-Lac-terminating ligands. 
Results and discussion 
AlicelIes formed from sodium dodecyl sulphate (SDS) 
ha\,e bren used as a model cell-membrane s)-stem to 
demonstrate the enhancement of acti\Aty through tem- 
plated binding 19,171. The system suffers from 3 number 
of distinct disaduntages, howex~er. ‘l’he high ncgati\ e- 
charge density on the surface and small radius of cur\‘a- 
turc of the miccllcs is unlikeI?- to alloyed the mauimum 
possible enhancement of acti\-ity. \-esicles. prepared 
from phosph3tid~lcholine (PC), mimic the actual cell 
membrane more closely. PC. which is ;1 component of 
cell membranes. forms ~1 t,ila) er structure rather than the 
single layer of lipid found in micelles. ‘I’hc significant 
increase in \olumc of \ esicles o\xr their micellular 
counterparts. v.ith concomitant increase in surface area 
and rcduction in radius of cur\ aturc, should considerably- 
reduce the strain within the ligand-dimer complex as the 
surface of the vesicle is closer to planarity. and therefore 
more similar to the surface of a bacterium. Additionally-, 
the net charge associated with the wxicle is zero. For 
these reasons, I.esiclcs h21x.e no\v replaced micelles in our 
experiments demonstrating ternplated binding at cell- 
wall surfaces (Figilrc 2) [8]. 
Cell-\v311-precursor analogue pzptides hakx been syithe- 
sised pre\ iously with hl;drophobic decanoyl and 
docosanoyl chains attached to the amino terminus [9.18] 
and they have been shown to anchor to model cell mem- 
branes such as vesicles [8,‘9]. 7’he arrangement of vesicle 
and anchored cell-n~all analogue is similar to the bacterial 
cell surface. \\-here the cell-\\a11 precursors arc anchored 
to the bilayer hy a (:i,i chain. Because of the large size of 
the \-esiclcs used (typically 100 nm diameter), an) 
species associated with a vesicle will take on the slo\\ 
tumbling properties (for rotation) of the vesicle itself, 
resulting in almost total broadening of nuclear magnetic 
resonance (IV\TIIR) signals. This effect can bc used to 
determine whether complexes are anchored to the 
\csicle surface [8J. 
In prwious ‘H _UAIR competition cxperimcnts. the 
antibiotic was antagonised from the surfwe-hound ligand 
under study by another ligand of known binding affiniq 
to the antibiotic [X,9]. The proportion of antibiotic bound 
to the vzsicle in these cuperimcnts was determined t)! 
integration of certain peaks corresponding to aromatic 
protons on the antibiotic. This analysis is complicated b!- 
neighbotiring o\-erlapping resonances and a variation in 
the degree of broadening of those resonances. Furthcr- 
more. it is difficult to obtain accurate integrals of small 
puks when much larger peaks. SIIC~ ;1s residual u atcr, are 
present in the spectra. ‘The USC of “‘F iK.\IR and a fluori- 
nated ligand has 2 number of distinct adwntages otter the 
pruious methods. The spectra arc far simpler and casicr 
to obtain than ‘11 XIIR spectra because of the absence of 
an\ other 1°F signals in the sample. For example. thcrc is 
no need for sol\ cnt suppression and the difficulties asso- 
ciutcd Lvith recciI-er gain in the ohscr\xtion of small 
signals in a mi\;ture arc significantly reduccci. ‘I’his results 
in spectra that arc easier to interpret and leads to more 
auxlratc integrals. Second. with the use of a fluorinated 
ligand as the antagonist. the onI> obser\-cd signals would 
be those for fluorinated ligand bound, and not bound, to 
antibiotic. The bound signal would represent fluorinated 
ligand that had successfully competed antibiotic from the 
~csicle (Figure 3). A fluorinated species of known con- 
centration was used as an evtrrnal reference. and the 
integrals of the signals u.cre used as a direct measure of 
the concentration of the relel ant species prcscnt, alloy- 
ing the calculation of the binding affinities of the 
anchored ligands. ‘l-he “)I; lahcl UYIS readil>- introduced 
into the ~required ligands by tritluoroacct~lation of the 
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Figure 2 
The size of an antiblotic dimer compared to 
both a sodium dodecyl sulfate (SDS) mlcelle 
and a phosphatidylcholine (PC) vesicle. It is 
clear that the vesicle will much more closely 
approximate the flatter surface found on a 
bacterial membrane than an SDS micelle. 
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Chemistry & Btology 
Iysinc rcsirluc. ;I method used st~ccessflill~ in pm ious 
\\olk [l’,]. 
‘I‘0 obtain useful rcriilts from competition cxpcrimcnts. Pre\.ious \\ork has denionstratcd that the 115c of ;I 
the conipcting li,q;anci must ha\e a binding affinit\ of tlecano~ I chain attached to dcpsipeptides c;iii Icacl to 
\iniilar niagnitudc to that of the tcmplatcd complex. The templatrd binding enhancenicnts, hut only \vith 
pcptidc .\‘-cc-acct~l-~~-&-tritl~ioro~~cet~l-l~s~l-l~-~~l~~i~~l- pcptides long ciio~igl~ to ;illo\\. the alli\ chain to insert 
Ibal~~nine (‘l’l;.~c-‘l’ri-_-\la) \\;is therefore synthc\iseci. 2s into the memhl-ane [VI. For this reason UC chose to stud!, 
it was espcctcd to ha\c :I bindin, L u 3ffinitv similar to that :I writs of lig;incls. in\estig:iting the effect of chain 
of the nontluorinatcd tripeptide .\c-‘l’ri-.\la. ‘I’he binding length on ternplated binding cnhancemcnts. I:i\c 
dffinit? of this ligand to (:E. as dcterrnincd Ix ultra- 
\ iolct (I.\‘) diffcrencc spectrophotometr~ [G]. 
depsipcptidc ligands \vcrc stiidicrl: .\-a-acct) I-.\%- 
\vas acctyl-lb-s) I-I)-alan~l-I)-lactate (.Ac-‘l‘i-i-I.:ic), .\.-a-acctyl- 
7.7 f 0.1 x IO \I-‘. \T.hich is similar to the \aluc of I~-y-glutain~l-.\‘-E-~icet~-l-l~s~-l-I,-alan~-l-l~-lact;ite ( \c- 
1.3 X 10” \I-’ for Ac-‘l’ri-.Ala [lO]. 3s antibiotic diincrisa- Tetra-kc).. A\‘-a-decmo~ lb,-y-glutam? I-,\‘-E-acet) I-I! s! l- 
tion is 311 important factor in producing a strongly tcn- I)-alliii~l-I)-lactate (Ike-‘l‘ctra-I .a~). .\‘-cc-docosa~~o~ I- I j-y 
pl:rtcd complc\. the antibiotic chosen for this study \\.;Is gltitam!-l-,\T&-a~~t~ I-l!.s!I-I)-alan).l-I)-lact~rtc (I >oc-‘I’ctw 
c:E:. u hich has 3 high ciinierisation constant (Kc,,,,, = Ix). ;u1d .\‘-a-docosano) I-gly C) I-dllll~ I-I,-y-glllt;llll~ I- 
1.1 X 10’ 11 -I \vhcn hound. Kc,,,,, = 1.8 X 10’ 11-l lvhen .\-&-acct~l-l~s~l-I)-~ilsn~l-I)-lactate (I>oc-I lexa-I,ac). ‘l’hc 
free) 1.51. 2nd ;i stron g affinit\ foi- cell-\\-all-l~rcctlrsor :III;I- , 
logties (I:igurc 4) [ 101. 
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Figure 3 
Free ligand Bound ligand , 
Docosanoyl ligand complex AntibiotIc displaced into free solution 
anchored on vesicle by fluorinated ligand 
Chemistry & Biology 
The concept behind the lgF NMR competition 
experiments. A higher concentration of 
unanchored fluorinated ligand is required to 
displace more strongly bound antibiotic 
dimers. Shown are the species responsible 
for the free and bound signals in the igF NMR 
experiments. 
affinities of Ac-Tri-1,x and Ac-Tetra-Lac were measured concentration [21,22]. The remaining ligand affinities 
in solution by the method of monitoring the chemical were all measured using the IoF NhlR method in the 
shift of the 1~~ proton (Figure 1) with increasing ligand presence of vesicles. Note that the broadness of antibiotic 
Figure 4 
+H,N 
Exploded view of the complex formed 
between CE and the fluorinated ligand 
TFAc-Tri-Ala. The wp proton is indicated. 
NHCOCF, Chemlstry & Biology 
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rcsonanccs when bound to 3 vesicle precludes the LISC of 
the \vL method in these cases. 
In all “‘I: NnlR experiments, an external rcfcrence of 
trifluoromethanesrllfonic acid (‘I’fOH) of kno\vn concen- 
tration M 3s used to convert relative integrals to concentra- 
tions. ‘I’hc concentration of the TfOH reference a-as 
calibrated from a spectrum of the external reference with a 
TF.\c-Tri-Ala solution of known concentration. To calcu- 
Iate the binding affinities of the ligands to (ZE, an ec4ua- 
tion MXS deri\cd from 3 consideration of the known 
species and the equilibria in\.olved. 
The two competing equilibria are: 
and: 
(1) 
(2) 
Equation 1 describes the cquilihrium existing bctn,een 
bound and unbound fluorinated ligand. M here f represents 
fret TFAc-Tri-Ala, ;I represents free antibiotic, and q rep- 
resents ‘I‘FAc-Tri-Xla hound to antibiotic. Equation 2 
describes the same situation for the ligand anchored to the 
\uicle. where I represents unbound anchored ligand. and 
;I, represents anchored ligand bound to antibiotic. ‘I’hcsc 
lead to expressions for E;,- and E;,, which arc the corre- 
sponding binding constzmts. Also rele\.ant are the mass 
balance cxprcssions relating total ;Intihiotic and anchored 
lig;lnd concentrations. These arc: 
[a,] = [a,\ + [a<] + [a] (3) 
II,1 = III + Ia,1 (1) 
\r.herc q and 1, arc the tot31 concentrations of antibiotic 
and anchored ligand respecti\,ely. From a consideration of 
these equations. it is possible to obtain an expression for 
IC, (SW Supplenicnt3ry material): 
h  =  x+[L-[g 
’ m-?)~ (5) 
btl kvhcre x = [a,] - [a+.] - [I,]. and [a] = r 
[flht 
It should be noted that the true dimensions of the 
surface-binding constant Ii, arc not hl-’ hut quoting 
them as such provides a useful quantitative reference to 
solution binding const3nts [Xl. 
Figures 5 and 6 sholv the results of t\vo ‘lJI; NhIR titration 
experiments with the dcpsipeptidcs Dee-‘l’ctra-Lac and 
DOGHexa-1,~ in the presence of vesicles. and 3 portion 
of the spectu from the corresponding ‘H X\IR hroadcn- 
ing experiments. Also sh0u.n is the relevant portion of the 
‘H NlllR control spectrum - that of (:E: and ligand with 
no vesicles. ‘I‘hc first series of spcctr:) are those for the 
study of binding to Dee-Tetra-Lac (Figure 5). Xote that 
in the _ ,~ ‘“F YhIR spectra only t\\.o signals ;irc present - 
those representing free ligand and ligand bound to antihi- 
otic (Figure Sa). ITsing the equation deri\.cd p-c\ iously. 
the affinity of Dee-‘I’etra-I,ac for the antibiotic is calcu- 
lated to 1~ 1.0 x lO-‘hI-‘. Although this \.alue is greater 
than that for Au-‘l’ri-Lac (920 \lb’). within expcrimcntal 
error it is the same 3s that for Ac-‘I’ctra-l,ac (‘l’ahlc 1 ). An 
important conclusion can be deri\ cd from the ;lbo\.c 
data: wen in free solution hc-Tctra-I,ac binds to (:F: 
more strongly than dots Xc-‘l’ri-Lac h> ;I factor of - 13. 
‘l’he difference hetlvccn the tri- and terra-dcpsipeptidcs 
is that of ;I I)-glutamate (I>-Glu) residue in the latter com- 
pound. It must he concluded that the IMGIu rcsidrle pro- 
motes much stronger binding to CE. It is striking that. 
from a ‘H iX.\lK stud? of the binding of A cell-uall ;III;I- 
loguc terminating in alan~l-I)-glIltam!l-,\‘-Llcet~l-l~s~l- 
I)-alan! I-Dalanine to CE [Z]. the y-c;lrhox!~l grollp of 
the I)-Glu residue is concluded to hc in 3 close prosiniit)- 
to the NH’+ group of the ~-r,~i-\.ancosaminc. \\ hich is 
;lttached to residue 1 lia glucose. Although the stud) did 
not propose that significant binding might clcri\,c from 
such an interaction, we suggest that in the GIX of the 
binding of Ac-Tctra-Lac to (:I:, the interaction iy prolw- 
bly largely the origin of the increased affinit>- rcl;tti\e to 
Ac-‘I‘ri-Lat. If the Dee-Tctra-Lac system \z cre templatcd 
on the stlrf:lce of the \esiclcs then one u~oulti c\-pect to 
observe Amost total broadening of signals in the ‘H N\lR 
spectrum (Figure .ic) [8\. ‘I‘he distinct ILIck of broadening 
in the spectrum v ith vesicles (rclati\e to the spectrum in 
the Llbsencc of vesicles; compre Figure 5b :rnd 5~) is in 
;igrcement with the “‘F NhlR result in so m11ch as it con- 
firms that little or no ternplating is occlirring. ‘I’he 
binding affinit\- \vas 31~0 calculated, in the ahscnce of 
vesicles. using the method of following the chemical shift 
of the \\., proton \vith :I range of Iigand conccntr:itions 
[Zl.ZZ], and the result wits in cxcellcnt agrcenient with the 
“‘I; \JhlK method. again indicating that. in the 1°F h1\IR 
experiment, no templatcd binding \vas oculrring (‘1’3blc 11. 
‘I’hc second series of spectra arc for the ligand I)oc- 
Hexa-Lac (Figure 6). hate the l:lrgc increase in the 
binding affinity of the anchored docosa~io~i iigand for 
CE. apparent from the pesk for free TFXc-‘l’ri-:\la being 
significantI>- mow intense than the Ix~und peak for all 
conccntutions of ‘I’F.L\c-Tri-Als (Figure (XI). In this C:NC. 
the system benefits from the coopcrati\.c cnhanccmcnt 
to bc gained from ternplating that results from the ligand 
being long enough to ~~110~ insertion of the docownoyl 
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Figure 5 
(a) 
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Chemstry & Biology 
chain into the membrane. This system gi\-es the largest 
enhancement seen for 3 depsipeptide ligand as deter- 
mined using the l”F NnlR method, the binding affinig 
being calculated as 2.5 x IO’ .\I-‘. The ‘H K.\lR data 
(Figure 6b.c) are again in agreement with the “‘F NhlR 
data in [hat there is exwnsivc broadening of the signals 
in the presence of \.esicles (Figure hc). indicati\re of a 
ternplated system. There is a notable difference 
betlveen Figure Sb and Figure 61~. ho\ve\er. The former 
NMR spectra showing lack of efficient 
templated binding to Dee-Tetra-Lat. (a) Plot 
showing the lgF NMR spectra from a titration 
of TFAc-Tri-Ala into a solution of CE (0.5 mM), 
Dee-Tetra-Lac (1.5 mM), and 100 nm 
10 mM PC vesicles in 9:l 0.1 M phosphate 
buffer:D,O at 298 K. Note that the bound 
peak dominates the spectra for all 
concentrations of TFAc-Tri-Ala (shown for 
each titration point), indicating a relatively low 
binding affinity of the depsipeptide for CE. 
(b) Portion of the ‘H NMR spectrum of 
0.2 mM CE and 1 .O mM Dee-Tetra-Lac in the 
absence of vesicles. (c) Portion of the 
‘H NMR spectrum of 0.2 mM CE and 1 .O mM 
Dee-Tetra-Lac in the presence of 100 nm 
10 mM PC vesicles. The lack of extensive 
broadening in the spectrum relative to (b) IS 
indicative of a nontemplated system. 
spectrtlm is characteristic of CE bound to cell-wall ana- 
logucs in solution. Lvhereas the latter is characteristic of 
CE in its free state. The ‘H SRIR spectrum of CE in 
Figure hb illustrates that as 1 m\l DOGHexa-LX is 
abo\.e its critical micelle concentration (0.10 m11) the 
Dot-Hexa-Lac is not a\%lable to bind CE (presumably 
due to steric cro\vding of many depsipeptide termini at 
the surface of the micelle). Table 1 summarises the 
results obtained. 
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Figure 6 
NMR spectra illustrating templated blnding to 
Dot-Hexa-Lat. (a) Plot showing the jgF NMR 
spectra from a titration of TFAc-Tri-Ala into a 
solution of CE (0.2 mM), Dot-Hexa-Lac 
(1 .O mM), and 100 nm 10 mM PC vesicles in 
9:l 0.1 M phosphate buffer:D,O at 298 K. 
Now the appearance of the titration is 
reversed relative to Figure 5, the free peak 
dominating each titration point at all 
concentrations of TFAc-Tri-Ala. (b) Portion of 
the ‘H NMR spectrum of 0.2 mM CE and 
1 .O mM Doe-Hexa-Lac in the absence of 
vesicles. (c) Portion of the ‘H NMR spectrum 
of 0.2 mM CE and 1 .O mM Dot-Hexa-Lac in 
the presence of 100 nm 10 mM PC vesicles. 
The total broadening relative to (b) indicates a 
templated system with this depslpeptide. 
(a) 6 
I’ Free p ak ,; / 
I ( :.i/- 
ppm 
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Significance to be approached in solution, so there is less to gain 
For the vancomycin group of antibiotics, there is likely to through the addition of extra interactions SLICII as templat- 
be an intrinsic upper limit for their binding affinities to ing. The binding of the ligand Dot-Tri-Ala to chloroere- 
cell-wall analogues [8,11]. In the case of strongly binding momycin (CE) on a surface has been measured using 
II-alnnine (D-Ala) terminating ligands this limit is like11 surface plasmon resnnance, giving a value of 2 x 10’ Wl 
336 Chemistry & Biology 1998, Vol 5 No 6 
Table 1 
Binding constants of various depsipeptides to CE in the 
presence of PC vesicles, from lgF NMR competition 
experiments, and in the absence of vesicles, from the w2 
method. 
Llgand ‘9F NMR (M-‘) w, (M-‘) 
AcKDADLac 
AcDEKDAoLac 
decDEKoAoLac 
docoEKDADLac 
docGAoEKDAoLac 
920 f 50 
1.2~ 104+2000 
1 .o x 104 k 1900 9.0 x 103 f 2000 
2.2 x 1 O4 * 2400 
2.5x105k3x104 
The abbreviations used for the ligands are different from those used in 
the text. Single-letter amino-acid code is used here for the amino acids 
in the ligands. 
enhancement possible from initially looser complexes 
offers a self-consistent explanation for this phenomenon. 
Materials and methods 
Materials 
Type XVl-E L-cc-Phosphatidylcholine (99%, from fresh egg yolk) was 
purchased from Sigma. Solvents were purified accordmg to standard 
procedures [28]. 
Preparation of phosphatidylcholine vesicles 
Small unilamellar vesicles (SW/s) were prepared in 0.1 M phosphate 
buffer at pH 7 by extrusion [291. Type XVI-E L-cc-phosphatidylcholine 
from fresh egg yolk (Sigma, 64 mg, 80 mmol) was dissolved in ethanol- 
free chloroform (10 ml) in a 250 ml round bottom flask and deposited 
as a thin film after removal of the solvent under reduced pressure. The 
lipld was dned under high vacuum for 2 h, then phosphate buffer (8 ml) 
was added to give a 10 mM suspension. The lipid was shaken for 
30 mln, and was sonicated for 30 min to give a translucent solution. It 
was then passed between 17 and 21 times through a 100 nm pore 
size polycarbonate filter in an Avestln Lipofast BasicTM extrusion appa- 
ratus. This solution was then made up to a 9:l mixture of SUV:D,O. 
[24] compared to 1.3 x 10” M-l for Ac-Tri-Ala in solu- 
no significant enhancement in binding affinity to the gly- 
copeptides for II-Ala-terminating ligands [2]. We can 
tion [lo] - a 15fold enhancement. Increasing the 
therefore take this value of 2 x 10’ M-’ as being close to 
number of residues after lysine has been shown to offer 
the upper limit measurable within our model system. 
Indeed, the binding of D-Ala-terminating ligands seems 
to limit near to 10s M-1 on the surface of bacteria [II]. 
In the case of the D-lactate (D-Lac) terminating ligands, 
however, there is a greater potential to gain binding 
residues. Care must be taken to distinguish between the 
affinity through cooperative enhancements such as tem- 
plating. Thus, there is an enhancement of over 250-fold 
for Dot-Hexa-Lac (2.5 x 10S %I-‘) over the weak binding 
of Ac-Tri-Lac (920 M-l), d emonstrating that binding 
can increase significantly for peptides longer than three 
cone voltage of 40 V. The eluent was a 1 :l mixture of water and ace- 
tonitrlle with a flow rate of 4 pl min-‘. 
Mass spectrometry 
Electrospray mass spectra were recorded on a VG Bio-Q machine 
using a source temperature of 70°C, a capillary potential of 4 kV and a 
NMR spectroscopy 
All ‘H NMR expenments were performed on a Bruker DRX-500 spec- 
trometer at 298 K. One-dimensional spectra were recorded using 32k 
complex data points. 
All lgF NMR experiments were performed on a Bruker AM-400 spec- 
trometer equipped with a ‘gF/‘H probe at 298 K. One-dimensional 
spectra were typlcally recorded at 376.47 MHz using 8k complex data 
points over a spectral width of 6.9 ppm. 
General procedure for NMR titrations 
Titrations with vesicles. All titrations were performed at 298 K. The 
antlbiotic concentration used in all of the titrations was 0.2 mM, and the 
depslpeptide concentration 1 .O mM, with the exception of the titration 
enhancement fi-om templating and from other effects. for Dee-Tetra-Lac in which they were 0.5 mM and 1.5 mM respectively. 
For example, the increase in affinity- from Ac-Tri-Lac to The concentration of TFAc-Tri-Ala used was dependent upon the esti- 
Ac-Tetra-Lac is a result of the addition of the glutamate 
mated binding constant of the ligand: the higher the expected binding 
constant. the hiaher the concentration of TFAc-Tri-Ala. Durina the titra- 
binding in free solution to the same degree because the) 
do not interact significantly with the antibiotic [231. The 
residue. It is unlikely that further residues will affect the 
experiments illustrate the general principle that coopera- 
tive enhancements are likel?- to be relatively greater 
when the initial complex is loose. 
to 500 ~1 of the antibiotic/anchored ligand solution. All samples (antibi- 
U 
otic, ligand, TFAc-Tri-Ala) were prepared by dissolution in phosphate 
ti 
buffer (pH 7.4) with adjustment to pH 7.4 as required. These samples 
tion, a total of up to 50 pl of TFAc-Tri-Ala was added In IO PI allquots 
were lyophilised. The antibiotic and decanoyl/docosanoyl ligand were 
dissolved In a 9:l solution of SUV:D,O (without sonication), and TFAc- 
Tri-Ala was dissolved In 9:l phosphate buffer:D,O. 
Recently, derivatives of CE have been developed 
bearing hydrophobic groups on the 4-epi-vancosamine 
on the residue-4 disaccharide [25], and these hydropho- 
bic groups have been shown to act as membrane 
anchors [8,26]. These derivatised antibiotics show signif- 
icant activit\- against vancomycin-resistant gram-posi- 
tive bacteria [26,27] through strengthened binding on 
the bacterial surface [8,26], although any increase in 
activity against vancomycin-sensitive bacteria is less 
marked [27]. In combination with our previous work 
[8,9], the illustration here of the greater cooperative 
A sample of TfOH in water was used as an external reference (in a glass 
insert in the NMR tube) for both chemical shift and relative peak inte- 
grals. The TfOH concentration used (- 1 x 1 0m4 Mm’) was such that its 
corresponding peak in the lgF spectrum was of similar intensity to the 
other lgF resonances to be observed. The relative integral of the TfOH 
peak was calibrated from a spectrum of TFAc-Tri-Ala of known concen- 
tration containing this TfOH insert. In order to adjust for the loss of any 
19F signal from TFAc-Trl-Ala due to non-specific bmdlng of TFAc-Tn-Ala 
to the vesicle/ligand complex, an experiment was performed In which 
TFAc-Trl-Ala solution was titrated Into a solution of ligand and vesicles 
(ie., In the absence of antibiotic). Any such loss of lgF signal was below 
the limits of observation, however (~4%). This control was performed 
for each different llgand examined. Experiments demonstrating the non- 
association of CE for vesicles has previously been published [al. 
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Measurement of association constants by UV difference 
spectrophotometry 
All expenments were performed usrng a dual beam 940 spectropho- 
tometer equipped with a thermocrrculator maintaining a constant tem- 
perature of 25%. Two samples, each 2.5 ml of a 25 PM solution of 
chloroeremomycin dissolved In pH 6 0.10 M phosphate buffer, were 
placed in cuvettes, one being the sample cell and the other the refer- 
ence cell. A spectrum from 200 nm to 300 nm was then recorded. A 
ligand solution was prepared by dissolving ligand in the cuvette in the 
antrbiotic solution, so as to keep the concentratron of antibiotic In the 
cuvette constant, at a lrgand concentration such that (using an estimate 
for the binding constant) 1 ml of this solution added to the antibiotic 
solution would give rise to 95% of the antibiotic bound. 1 ml of this 
solution was then added to the cuvette containing the antibiotlc. The 
maximum changes In absorbance were observed to be at 264 and 
231 nm, and so these wavelengths were monitored throughout the 
subsequent titration. The titration was then carried out wrth a fresh 
antibiotic sample, with ligand solution being added in 10 pl aliquots, 
and the difference in absorbance between the two wavelengths noted. 
The association constant was determined by curve-fitting a plot of 
change in absorbance against ligand concentration using Kaleidagraph 
(Abelbeck Software). Determinations were always carried out in tripli- 
cate. the average result being quoted, with the error being derived from 
the result with the largest deviation from this average. 
Supplementary material 
The details of the synthesis of all peptides used in this study and the 
determination of an expression for K, are available on the internet. 
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